Clinical Trial

Chaigui Longmu Ejiao Paste for Ischemic Heart Disease

Name: Chaigui Longmu Ejiao Paste for Ischemic Heart Disease — clinical trial record (NCT07478328)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study explores whether Chaigui Longmu Ejiao Paste can reduce the average weekly number of angina attacks in patients with ischemic heart disease after 8 weeks of treatment, using Chaigui Longmu Paste without Ejiao as a parallel control and incorporating a synthesized external control.

Trial Details

NCT Number	NCT07478328
Lead Sponsor	Longhua Hospital Collaborators: Shanghai University of Traditional Chinese Medicine, DongE E Jiao Coporation Limited
Conditions	Ischemic Heart Disease
Enrollment	60 participants
Start Date	2026-03-08
Primary Completion	2027-03-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-17